6533b871fe1ef96bd12d1827
RESEARCH PRODUCT
336P PI3K pathway biomarkers and clinical response in a phase I/Ib study of GDC-0077 in hormone receptor-positive/HER2-negative breast cancer (HR+/HER2– BC)
Dejan JuricAndrés CervantesJunko AimiAntoine ItalianoKevin KalinskyErika HamiltonIan E. KropStephanie Royer-jooJennifer L. SchutzmanKatie HutchinsonKomal JhaveriJ. ChenBonnie LiuValentina GambardellaCristina SauraMafalda OliveiraN. TurnerPeter SchmidP. BedardAndreea Vargasubject
Breast cancerOncologybusiness.industryHormone receptorHER2 negativeCancer researchMedicineHematologybusinessmedicine.diseasePI3K/AKT/mTOR pathwayyear | journal | country | edition | language |
---|---|---|---|---|
2020-09-01 | Annals of Oncology |